Association Between Stress Hyperglycemia Ratio and Coronary Slow Flow Phenomenon in Patients with MINOCA

MINOCA患者应激性高血糖比值与冠状动脉慢血流现象之间的关联

阅读:2

Abstract

BACKGROUND: Myocardial infarction with non-obstructive coronary arteries (MINOCA) is a heterogeneous clinical entity in which coronary microvascular dysfunction plays a central pathophysiological role. The coronary slow flow phenomenon (CSFP) represents an angiographic manifestation of microvascular dysfunction; however, reliable and practical biomarkers for its identification remain limited. The stress hyperglycemia ratio (SHR) reflects acute metabolic stress beyond chronic glycemic status. This study aimed to investigate the association between SHR and CSFP in patients with MINOCA. METHODS: In this single-center retrospective cohort study, 2073 patients undergoing coronary angiography for suspected myocardial infarction between 1 January 2020 and 1 December 2025 were screened. 354 patients with MINOCA were included. Patients with CSFP were matched 1:2 with controls according to age and sex using exact matching. SHR and other laboratory parameters were assessed. Logistic regression and receiver operating characteristic (ROC) analyses were performed to identify independent predictors of CSFP. RESULTS: Among the study population, 118 patients (33.3%) had CSFP. Patients with CSFP had significantly higher SHR levels, along with increased C-reactive protein, triglycerides, low-density lipoprotein cholesterol, and uric acid, whereas HbA1c and serum albumin levels were lower (all p < 0.05). In multivariable logistic regression analysis, SHR emerged as the strongest independent predictor of CSFP (OR: 1.48, 95% CI: 1.30-1.69; p < 0.001). In ROC analysis, SHR demonstrated the highest discriminative performance for CSFP (AUC: 0.74), with an optimal cut-off value of 0.998, yielding a sensitivity of 66.1% and a specificity of 64.3%. CONCLUSION: SHR is independently associated with CSFP in patients with MINOCA, suggesting that acute metabolic stress plays a key role in coronary microvascular dysfunction. SHR may serve as a simple and readily available marker for identifying high-risk microvascular phenotypes in MINOCA patients.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。